Cancer care is expanding beyond medicine.
What’s happening: Thyme Care, a value-based oncology enabler, raised $97M Series D at a $1B valuation to expand access and support patients across survivorship.
Added context. Acting as a care navigator, Thyme tackles overlooked hurdles of treatment—from coordinating appointments and rides to shortening delays—while helping providers cut costly hospital readmissions.
By assuming financial risk, Thyme’s outcomes-dependent model is gaining partners, scaling from 10K to 80K patients since December while managing $5B in oncology spending.
Rising burden. Cancer cases are rising, with breast and colorectal incidences tracking younger. Yet, with advances in targeted treatments and diagnostics, five-year survivorship has improved to 91%.
But, for the 18.6M Americans living with cancer, the journey extends beyond treatment — spanning emotional support, financial stability, and the everyday logistics of care.
Lending wraparound support, Daymark Health just raised $20M to address clinical, social, and mental health, Jasper Health provides 1:1 virtual guidance, and Outcomes4Me acquired lifestyle support app Mika to build an AI-powered survivorship OS.
Punchline: For patients and caregivers, the cancer journey is filled with obstacles. As cases rise, care models must evolve to improve quality of life as well as extend it.
